Veraxa Biotech AG - Post de-SPAC — insider transactions

2 transactions on record · VRXA · CIK 2079109

Aggregates

computed from the filings below
Purchases, 12m
2
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
no sales recorded
Distinct insiders, 12m
2
Bought, 3m
$82.7K
Sold, 3m
$0
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$75K
2026-08-27
Director share, 12m
100.0%
of transactions where role is stated
Current run
2 buys
consecutive same-direction transactions
Net 3m flow
$82.7K
purchases minus sales
Total on record
2

Transactions

2 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-312026-08-274Antz Christoph RudigerDirector, Chief Executive OfficerOpen market purchase5,000$1.53$7.7Kfiling
2026-08-312026-08-274Baumann Oliver RolfDirectorOpen market purchase50,000$1.50$75Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR